Showing results (21-30 of 104) with videos related to

Sort By:
Pageof 11
Journal of Molecular Biology|February 15, 2011
The VD1 neutralizing antibody to vascular endothelial growth factor-D: binding epitope and relationship to receptor bindingNatalia Davydova, Sally Roufail, Victor A Streltsov, et al.
Current Cancer Drug Targets|December 27, 2005
Mechanisms of lymphangiogenesis: targets for blocking the metastatic spread of cancerBradley K McColl, Stephen J Loughran, Natalia Davydova, et al.
Best Practice & Research. Clinical Anaesthesiology|November 26, 2013
Lymphovascular and neural regulation of metastasis: shared tumour signalling pathways and novel therapeutic approachesCaroline P Le, Tara Karnezis, Marc G Achen, et al.
Nature Reviews. Cancer|February 25, 2014
Lymphangiogenesis and lymphatic vessel remodelling in cancerSteven A Stacker, Steven P Williams, Tara Karnezis, et al.
Frontiers in Immunology|January 10, 2017
The Role of the Tumor Vasculature in the Host Immune Response: Implications for Therapeutic Strategies Targeting the Tumor MicroenvironmentShona A Hendry, Rae H Farnsworth, Benjamin Solomon, et al.
Cancer Research|August 27, 2011
A role for bone morphogenetic protein-4 in lymph node vascular remodeling and primary tumor growthRae H Farnsworth, Tara Karnezis, Ramin Shayan, et al.
Growth Factors (Chur, Switzerland)|August 1, 2002
The angiogenic and lymphangiogenic factor vascular endothelial growth factor-D exhibits a paracrine mode of action in cancerMarc G Achen, Richard A Williams, Megan E Baldwin, et al.
Protein Expression and Purification|January 21, 2012
Preparation of human vascular endothelial growth factor-D for structural and preclinical therapeutic studiesNatalia Davydova, Victor A Streltsov, Sally Roufail, et al.
Growth Factors (Chur, Switzerland)|June 17, 2025
An endothelial cell competition assay for determinants of the response to targeted anti-angiogenicsMichael M Halford, Michael Y He, Nancy Amin, et al.
Pageof 11